Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCALL.L Regulatory News (CALL)

  • There is currently no data for CALL

PrimaryBid.com Offer

1 Mar 2021 17:03

RNS Number : 7658Q
Cloudcall Group PLC
01 March 2021
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES.

Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF CLOUDCALL GROUP PLC.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRNΒ 779021)

Β 

Β 

1 March 2021

Β 

CloudCall Group plc

("CloudCall" or the "Company")

PrimaryBid.com Offer

Β 

CloudCall (AIM: CALL; OTCQX: CLLLF),Β the integrated communications company that provides unified communications and contact centre software that tightly integrates with Customer Relationship Management ("CRM") platforms, is pleased to announce,Β a conditional offer for subscription via PrimaryBid (the "PrimaryBid Offer") for up to Β£1 million of new ordinary shares of 20 pence each in the Company ("New Ordinary Shares")Β at an issue price of 81.5 pence per New Ordinary Share (the "Issue Price"), being the closing mid-price on 1 March 2021. The Company is also conducting a placing of new Ordinary Shares at the Issue Price by way of an accelerated bookbuild process (the "Placing") as announced today.

The PrimaryBid Offer and the Placing are conditional on the new Ordinary Shares to be issued pursuant to the PrimaryBid Offer and the Placing being admitted to trading on AIM ("Admission").Β Admission is expected to be take place at 8.00 a.m. on 29 March 2021. The PrimaryBid Offer, which is subject to Shareholder approval in General Meeting on 25 March 2021, will not be completed without the Placing also being completed.

The Company will use the funds raised for general working capital, and to strengthen the Company's balance sheet.

PrimaryBid Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the PrimaryBid Offer by applying exclusively through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, via the PrimaryBid.com platform, will be open to individual and institutional investors immediately. The PrimaryBid Offer will close on completion of the Bookbuild process. The PrimaryBid Offer may close early if it is oversubscribed.

The Company in consultation with PrimaryBid reserves the right to scale back any order at its discretion. The Company and PrimaryBid reserve the right to reject any application for subscription under the Offer without giving any reason for such rejection.

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid.com or the procedure for applications under the PrimaryBid Offer, visitΒ www.PrimaryBid.comΒ or call PrimaryBid.com on +44 20 3026 4750.Β 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rankΒ pari passuΒ in all respects with the Company's existing Ordinary Shares.

CloudCall Group plc

Simon Cleaver, Chief Executive Officer

Paul Williams, Chief Financial OfficerΒ 

Β 

Β 

+44 (0) 20 3587 7188

PrimaryBid Limited

Fahim Chowdhury

James Deal

Β 

+ 44 (0) 203 026 4750

Canaccord Genuity Limited

Nominated Advisor, Sole Broker and Bookrunner

Simon Bridges

Richard Andrews

Thomas Diehl

Β 

Β 

+44 (0) 20 7523 8000

Details of the Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Offer. The Company is therefore making the Offer available exclusively through PrimaryBid.com.

The Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of aΒ prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

There is a minimum subscription of Β£100 per investor under the terms of the Offer which is open to existing shareholders and other investors subscribing via PrimaryBid.com.

For further details please refer to the PrimaryBid.com website atΒ www.PrimaryBid.com. The terms and conditions on which the Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt.Β 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Β 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
OUPEAKDFESNFEFA
Date   Source Headline
14th Aug 20197:30 amRNSSchedule 2(G) corrections
14th Aug 20197:00 amRNSAppointment of Nominated Adviser and Sole Broker
16th Jul 20197:00 amRNSTrading Statement
11th Jul 201911:00 amRNSTrading update webinar arrangements
18th Jun 20197:00 amRNSHolding(s) in Company
17th Jun 20193:44 pmRNSHolding(s) in Company
12th Jun 20197:00 amRNSNew CRM Integration
11th Jun 20197:00 amRNSHolding(s) in Company
7th Jun 201910:27 amRNSAdditional Block Admission and Total Voting Rights
4th Jun 20197:00 amRNSContract Win
21st May 20193:23 pmRNSResult of AGM
1st May 20194:34 pmRNSTotal Voting Rights
1st May 20193:49 pmRNSHolding(s) in Company
23rd Apr 20199:31 amRNSHolding(s) in Company
17th Apr 20194:07 pmRNSHolding(s) in Company
16th Apr 20192:06 pmRNSHolding(s) in Company
29th Mar 20197:00 amRNSHolding(s) in Company
27th Mar 20192:05 pmRNSSecond Price Monitoring Extn
27th Mar 20192:00 pmRNSPrice Monitoring Extension
27th Mar 20197:00 amRNSFinal Results
13th Mar 201911:29 amRNSNotice of Results
7th Feb 201912:40 pmRNSHolding(s) in Company
30th Jan 20198:41 amRNSResult of Placing
30th Jan 20197:00 amRNSPlacing
15th Jan 20197:00 amRNSTrading Statement
6th Dec 20187:00 amRNSCapital Markets Day
4th Dec 20185:52 pmRNSHolding(s) in Company
4th Dec 20185:51 pmRNSHolding(s) in Company
4th Dec 20183:42 pmRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSNotification of Trading Statement
30th Nov 201810:09 amRNSBlock Admission return & Total Voting Rights
12th Nov 201810:07 amRNSDirector/PDMR Shareholding
6th Nov 20182:52 pmRNSHolding(s) in Company
31st Oct 201812:00 pmRNSTotal Voting Rights
9th Oct 201812:21 pmRNSDirector/PDMR Shareholding
9th Oct 20187:00 amRNSDirector/PDMR Shareholding
8th Oct 20181:30 pmRNSHolding(s) in Company
8th Oct 201810:47 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSHalf-year Report
10th Sep 20188:51 amRNSNotice of Results and Webinar
10th Sep 20187:00 amRNSNotice of Results and Webinar
31st Aug 20184:23 pmRNSTotal Voting Rights
20th Jul 20187:54 amRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSHalf-year trading update
29th Jun 201812:49 pmRNSHolding(s) in Company
30th May 20181:57 pmRNSBlock Admission and Total Voting Rights
17th May 20187:00 amRNSLaunch of New Products
30th Apr 20184:28 pmRNSShare Option Exercise and Issue of Equity
27th Apr 20188:33 amRNSBlock Admission
23rd Apr 20184:47 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.